| |
| |
|
| Insider
Information: |
Oliviero James F Iii |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,221,014 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,803,382 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
2,221,014 |
|
|
| Total
Value |
$3,803,382 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
15
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
15
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-15.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -763.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Keryx Biopharmaceuticals Inc |
KERX |
Chief Financial Officer |
2015-07-06 |
209,406 |
2008-08-14 |
0 |
Premium* |
|
|
Checkpoint Therapeutics, Inc. |
CKPT |
CEO, President and Dir... |
2024-05-24 |
2,001,780 |
|
0 |
Premium* |
|
|
Nuvectis Pharma, Inc. |
NVCT |
Director |
2022-02-08 |
9,828 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
81 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KERX |
Keryx Biopharmaceuticals ... |
Vice President Finance |
• – – |
2008-08-14 |
4 |
A |
$0.00 |
$0 |
D/D |
280,000 |
280,000 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Vice President, Finance |
• – – |
2009-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
330,000 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2009-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
5,214 |
362,964 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2010-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
462,964 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2011-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
16,250 |
237,709 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2012-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
28,000 |
189,208 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2012-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
400,000 |
576,560 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2013-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
33,520 |
600,548 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2014-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
22,741 |
499,170 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2015-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
23,875 |
177,220 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO and President |
• – – |
2016-12-15 |
4 |
A |
$0.00 |
$0 |
D/D |
325,000 |
1,325,000 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO and President |
• – – |
2018-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
325,000 |
1,650,000 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2019-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
485,000 |
2,135,000 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2020-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
598,000 |
2,733,000 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2021-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
539,000 |
3,272,000 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2022-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
455,000 |
3,608,210 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2023-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
149,573 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2024-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
1,660,000 |
2,001,780 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2009-05-22 |
4 |
B |
$0.40 |
$9,925 |
D/D |
25,000 |
355,000 |
2.74 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2009-06-23 |
4 |
B |
$0.90 |
$2,472 |
D/D |
2,750 |
357,750 |
2.66 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2022-01-01 |
4 |
D |
$3.11 |
$941,636 |
D/D |
(302,777) |
3,305,433 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2022-01-06 |
4 |
D |
$2.77 |
$146,876 |
D/D |
(53,024) |
3,252,409 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2022-01-24 |
4 |
D |
$2.19 |
$313,468 |
D/D |
(143,136) |
3,109,273 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2022-01-30 |
4 |
D |
$2.46 |
$78,651 |
D/D |
(31,972) |
3,077,301 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2022-02-24 |
4 |
D |
$1.85 |
$217,665 |
D/D |
(117,657) |
2,959,644 |
0 |
- |
|
81 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
